224
Views
0
CrossRef citations to date
0
Altmetric
ORIGINAL RESEARCH

Combination of TyG Index and GRACE Risk Score as Long-Term Prognostic Marker in Patients with ACS Complicated with T2DM Undergoing PCI

, , , , , , , , , , , & show all
Pages 3015-3025 | Received 25 May 2022, Accepted 08 Sep 2022, Published online: 28 Sep 2022

References

  • Roth GA, Mensah GA, Johnson CO, et al. Global burden of cardiovascular diseases and risk factors, 1990–2019: update from the GBD 2019 study. J Am Coll Cardiol. 2020;76(25):2982–3021. doi:10.1016/j.jacc.2020.11.010
  • Smith JN, Negrelli JM, Manek MB, Hawes EM, Viera AJ. Diagnosis and management of acute coronary syndrome: an evidence-based update. J Am Board Fam Med. 2015;28(2):283–293. doi:10.3122/jabfm.2015.02.140189
  • Einarson TR, Acs A, Ludwig C, Panton UH. Prevalence of cardiovascular disease in type 2 diabetes: a systematic literature review of scientific evidence from across the world in 2007–2017. Cardiovasc Diabetol. 2018;17(1):83. doi:10.1186/s12933-018-0728-6
  • Naito R, Miyauchi K. Coronary Artery Disease and Type 2 Diabetes Mellitus. Int Heart J. 2017;58(4):475–480. doi:10.1536/ihj.17-191
  • Poznyak A, Grechko AV, Poggio P, Myasoedova VA, Alfieri V, Orekhov AN. The Diabetes Mellitus-Atherosclerosis Connection: the Role of Lipid and Glucose Metabolism and Chronic Inflammation. Int J Mol Sci. 2020;21:5. doi:10.3390/ijms21051835
  • Mirr M, Skrypnik D, Bogdański P, Owecki M. Newly proposed insulin resistance indexes called TyG-NC and TyG-NHtR show efficacy in diagnosing the metabolic syndrome. J Endocrinol Invest. 2021;44(12):2831–2843. doi:10.1007/s40618-021-01608-2
  • Zhao Q, Zhang TY, Cheng YJ, et al. Triglyceride-glucose index as a surrogate marker of insulin resistance for predicting cardiovascular outcomes in nondiabetic patients with non-ST-segment elevation acute coronary syndrome undergoing percutaneous coronary intervention. J Atheroscler Thromb. 2021;28(11):1175–1194. doi:10.5551/jat.59840
  • Guo Q, Feng X, Zhang B, et al. Influence of the Triglyceride-Glucose Index on Adverse Cardiovascular and Cerebrovascular Events in Prediabetic Patients With Acute Coronary Syndrome. Front Endocrinol (Lausanne). 2022;13:843072. doi:10.3389/fendo.2022.843072
  • Ascenzo F, Biondi-Zoccai G, Moretti C, et al. TIMI, GRACE and alternative risk scores in acute coronary syndromes: a meta-analysis of 40 derivation studies on 216,552 patients and of 42 validation studies on 31,625 patients. Contemp Clin Trials. 2012;33(3):507–514. doi:10.1016/j.cct.2012.01.001
  • Lu PJ, Gong XW, Liu Y, et al. Optimization of GRACE risk stratification by N-terminal pro-B-type natriuretic peptide combined with D-dimer in patients with non-ST-elevation myocardial infarction. Am J Cardiol. 2021;140:13–19. doi:10.1016/j.amjcard.2020.10.050
  • Levine GN, Bates ER, Bittl JA, et al. 2016 ACC/AHA guideline focused update on duration of dual antiplatelet therapy in patients with coronary artery disease: a report of the American College of Cardiology/American heart association task force on clinical practice guidelines. Circulation. 2016;134(10):e123–55. doi:10.1161/CIR.0000000000000404
  • Cefalu WT, Berg EG, Saraco M, Petersen MP, Uelmen S, Robinson S. Classification and diagnosis of diabetes: standards of medical care in diabetes-2018. Diabetes Care. 2018;41(Suppl1):S13–S27. doi:10.2337/dc18-S002
  • Cho NH, Shaw JE, Karuranga S, et al. IDF Diabetes Atlas: global estimates of diabetes prevalence for 2017 and projections for 2045. Diabetes Res Clin Pract. 2018;138:271–281. doi:10.1016/j.diabres.2018.02.023
  • Wang XL, Zhang W, Li Z, et al. Vascular damage effect of circulating microparticles in patients with ACS is aggravated by type 2 diabetes. Mol Med Rep. 2021;23:6. doi:10.3892/mmr.2021.12113
  • Yaribeygi H, Farrokhi FR, Butler AE, Sahebkar A. Insulin resistance: review of the underlying molecular mechanisms. J Cell Physiol. 2019;234(6):8152–8161. doi:10.1002/jcp.27603
  • Galicia-Garcia U, Benito-Vicente A, Jebari S, et al. Pathophysiology of type 2 diabetes mellitus. Int J Mol Sci. 2020;21:17. doi:10.3390/ijms21176275
  • Beneit N, Martín-Ventura JL, Rubio-Longás C, et al. Potential role of insulin receptor isoforms and IGF receptors in plaque instability of human and experimental atherosclerosis. Cardiovasc Diabetol. 2018;17(1):31. doi:10.1186/s12933-018-0675-2
  • Lee M, Kim CH, Kim Y, et al. High triglyceride glucose index is associated with poor outcomes in ischemic stroke patients after reperfusion therapy. Cerebrovasc Dis. 2021;50(6):691–699. doi:10.1159/000516950
  • Guo W, Zhao L, Mo F, et al. The prognostic value of the triglyceride glucose index in patients with chronic heart failure and type 2 diabetes: a retrospective cohort study. Diabetes Res Clin Pract. 2021;177:108786. doi:10.1016/j.diabres.2021.108786
  • Zhang Y, Ding X, Hua B, et al. High triglyceride-glucose index is associated with adverse cardiovascular outcomes in patients with acute myocardial infarction. Nutr Metab Cardiovasc Dis. 2020;30(12):2351–2362. doi:10.1016/j.numecd.2020.07.041
  • Roffi M, Patrono C, Collet JP, et al. 2015 ESC guidelines for the management of acute coronary syndromes in patients presenting without persistent ST-segment elevation: task force for the management of acute coronary syndromes in patients presenting without persistent ST-segment elevation of the European Society of Cardiology (ESC). Eur Heart J. 2016;37(3):267–315. doi:10.1093/eurheartj/ehv320
  • Fox KA, Eagle KA, Gore JM, Steg PG, Anderson FA. The Global Registry of Acute Coronary Events, 1999 to 2009–GRACE. Heart. 2010;96(14):1095–1101. doi:10.1136/hrt.2009.190827
  • Chen X, Shao M, Zhang T, et al. Prognostic value of the combination of GRACE risk score and mean platelet volume to lymphocyte count ratio in patients with ST-segment elevation myocardial infarction after percutaneous coronary intervention. Exp Ther Med. 2020;19(6):3664–3674. doi:10.3892/etm.2020.8626
  • Wang L, Cong HL, Zhang JX, et al. Triglyceride-glucose index predicts adverse cardiovascular events in patients with diabetes and acute coronary syndrome. Cardiovasc Diabetol. 2020;19(1):80. doi:10.1186/s12933-020-01054-z
  • Fox KA, Fitzgerald G, Puymirat E, et al. Should patients with acute coronary disease be stratified for management according to their risk? Derivation, external validation and outcomes using the updated GRACE risk score. BMJ Open. 2014;4(2):e004425. doi:10.1136/bmjopen-2013-004425
  • Carvalho L, Bogniotti L, de Almeida O, et al. Change of BNP between admission and discharge after ST-elevation myocardial infarction (Killip I) improves risk prediction of heart failure, death, and recurrent myocardial infarction compared to single isolated measurement in addition to the GRACE score. Eur Heart J Acute Cardiovasc Care. 2019;8(7):643–651. doi:10.1177/2048872617753049
  • Kawai T, Nakatani D, Yamada T, et al. Clinical impact of estimated plasma volume status and its additive effect with the GRACE risk score on in-hospital and long-term mortality for acute myocardial infarction. Int J Cardiol Heart Vasc. 2021;33:100748. doi:10.1016/j.ijcha.2021.100748
  • Ma X, Han K, Yang L, et al. Adjustment of the GRACE risk score by monocyte to high-density lipoprotein ratio improves prediction of adverse cardiovascular outcomes in patients with acute coronary syndrome undergoing percutaneous coronary intervention. Front Cardiovasc Med. 2021;8:755806. doi:10.3389/fcvm.2021.755806
  • Öncel CR. Value of neutrophil-to-lymphocyte ratio and its combination with GRACE risk score in predicting PCI outcomes in acute coronary syndrome. Anatol J Cardiol. 2016;16(6):452. doi:10.14744/AnatolJCardiol.2016.6989